{"text": ["Roche", "Gets", "FDA", "Approval", "for", "New", "Formulation", "of", "Asthma", "Drug"], "created_at": "2018-10-01 20:52:21"}
{"text": ["Roche", "Gets", "FDA", "Approval", "for", "New", "Formulation", "of", "Asthma", "Drug"], "created_at": "2018-10-01 20:52:21"}
{"text": ["Is", "WisdomTree", "International", "High", "Dividend", "Fund", "(DTH)", "a", "Hot", "ETF", "Right", "Now?"], "created_at": "2018-10-01 17:53:51"}
{"text": ["Is", "WisdomTree", "International", "High", "Dividend", "Fund", "(DTH)", "a", "Hot", "ETF", "Right", "Now?"], "created_at": "2018-10-01 17:53:51"}
{"text": ["Rare", "manufacturing", "glitch", "raises", "concern", "over", "CAR-T", "therapies:", "study"], "created_at": "2018-10-01 15:53:21"}
{"text": ["How", "GlaxoSmithKline\u2019s", "Pharmaceutical", "Business", "Performed"], "created_at": "2018-10-01 14:32:44"}
{"text": ["Novan\u2019s", "Phase", "2", "Molluscum", "Contagiosum", "Trial", "Fully", "Enrolled:", "Top", "Line", "Results", "Targeted", "in", "November"], "created_at": "2018-10-01 12:05:00"}
{"text": ["GlaxoSmithKline\u2019s", "Revenue", "Was", "Flat", "in", "Second", "Quarter"], "created_at": "2018-10-01 11:33:48"}
{"text": ["Dr.", "Reddy's", "Launches", "Imatinib", "Mesylate", "Tablets", "In", "U.S.", "-", "Quick", "Facts"], "created_at": "2018-10-01 02:01:00"}
{"text": ["Dr.", "Reddy's", "Launches", "Imatinib", "Mesylate", "Tablets", "In", "U.S.", "-", "Quick", "Facts"], "created_at": "2018-10-01 02:01:00"}
